review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Alex Dyson | Q80033125 |
P2093 | author name string | Mervyn Singer | |
Eloise Evans | |||
Kavitej Samra | |||
Mathun Kuganesan | |||
P2860 | cites work | Selenosugars are key and urinary metabolites for selenium excretion within the required to low-toxic range | Q24541471 |
Essential role for mitochondrial thioredoxin reductase in hematopoiesis, heart development, and heart function | Q24563493 | ||
Different catalytic mechanisms in mammalian selenocysteine- and cysteine-containing methionine-R-sulfoxide reductases | Q24814982 | ||
From selenium to selenoproteins: synthesis, identity, and their role in human health | Q27863358 | ||
Protection against reactive oxygen species by selenoproteins | Q27863399 | ||
Selenoprotein R is a zinc-containing stereo-specific methionine sulfoxide reductase | Q27936169 | ||
Biological Chemistry of Hydrogen Selenide | Q28069453 | ||
Selenium Deficiency and Viral Infection | Q28202394 | ||
H2S induces a suspended animation-like state in mice | Q28246406 | ||
Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group | Q28260147 | ||
Cytoplasmic thioredoxin reductase is essential for embryogenesis but dispensable for cardiac development | Q28510029 | ||
The selenoprotein GPX4 is essential for mouse development and protects from radiation and oxidative damage insults | Q28587364 | ||
Selenite is a substrate for calf thymus thioredoxin reductase and thioredoxin and elicits a large non-stoichiometric oxidation of NADPH in the presence of oxygen | Q28627251 | ||
Characterization of selenocysteine lyase in human tissues and its relationship to tissue selenium concentrations | Q28627325 | ||
Enzymatic synthesis of selenocysteine in rat liver | Q28628311 | ||
Physiological functions of thioredoxin and thioredoxin reductase | Q29615600 | ||
A Long-Term and Slow-Releasing Hydrogen Sulfide Donor Protects against Myocardial Ischemia/Reperfusion Injury | Q30855744 | ||
Centrilobular endothelial cell injury by diquat in the selenium-deficient rat liver | Q32090151 | ||
Selenium and coronary heart disease: a meta-analysis | Q33259508 | ||
Selenoproteins regulate macrophage invasiveness and extracellular matrix-related gene expression | Q33513325 | ||
[Usual values of selenium and glutathione peroxidase in a Belgian population] | Q69595342 | ||
Selenium enhances prostacyclin production by cultured endothelial cells: possible explanation for increased bleeding times in volunteers taking selenium as a dietary supplement | Q70365597 | ||
Relations between the selenium status and the low T3 syndrome after major trauma | Q71549350 | ||
Human thioredoxin reductase directly reduces lipid hydroperoxides by NADPH and selenocystine strongly stimulates the reaction via catalytically generated selenols | Q72223385 | ||
Identification of a major selenium excretory product in rat urine | Q72350373 | ||
Trimethyl selenide. A urinary metabolite of selenite | Q72372841 | ||
Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study | Q72528718 | ||
Respiratory excretion of selenium | Q72901845 | ||
[Selenium administration in patients with sepsis syndrome. A prospective randomized study] | Q73998501 | ||
Excretion of dimethyl selenide by the rat | Q76172808 | ||
Selenium, systemic immune response syndrome, sepsis, and outcome in critically ill patients | Q77343304 | ||
Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock | Q79345186 | ||
Serum selenium levels and all-cause, cancer, and cardiovascular mortality among US adults | Q80771594 | ||
[Investigation of antioxidant therapy with sodium selenite in acute pancreatitis. A prospective randomized blind trial] | Q81146313 | ||
High-dose selenium substitution in sepsis: a prospective randomized clinical trial | Q83469277 | ||
Selenium and selenoproteins in health and disease | Q84884975 | ||
Selenide Targets to Reperfusing Tissue and Protects It From Injury | Q87077251 | ||
Selenium Homeostasis and Clustering of Cardiovascular Risk Factors: A Systematic Review | Q89768493 | ||
Selenomethionine relieves inflammation in the chicken trachea caused by LPS though inhibiting the NF-κB pathway | Q92036891 | ||
Global transcriptomic analysis of the arcuate nucleus following chronic glucocorticoid treatment | Q92604748 | ||
Chemistry, pharmacology, and cellular uptake mechanisms of thiometallate sulfide donors | Q92695268 | ||
Selenocysteine β-Lyase: Biochemistry, Regulation and Physiological Role of the Selenocysteine Decomposition Enzyme | Q93080552 | ||
Serum selenium and the risk of coronary heart disease and stroke | Q93588339 | ||
Selenocysteine-containing proteins in mammals | Q33644308 | ||
Selenium | Q33670219 | ||
Low plasma selenium concentrations in critically ill children: the interaction effect between inflammation and selenium deficiency | Q33821931 | ||
Ammonium tetrathiomolybdate following ischemia/reperfusion injury: Chemistry, pharmacology, and impact of a new class of sulfide donor in preclinical injury models. | Q33873758 | ||
Selenoproteins: molecular pathways and physiological roles. | Q33913069 | ||
Oxidative stress in critically ill patients. | Q33962419 | ||
Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter? | Q34157091 | ||
Selenocysteine lyase, a novel enzyme that specifically acts on selenocysteine. Mammalian distribution and purification and properties of pig liver enzyme. | Q34261197 | ||
Selenium, selenoproteins and human health: a review | Q34421304 | ||
Selenium and human health. | Q34636304 | ||
Effects of selenium supplementation on selenoprotein gene expression and response to influenza vaccine challenge: a randomised controlled trial | Q34703915 | ||
Selenium, an antioxidant nutrient | Q34756127 | ||
Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death | Q34818662 | ||
Selenium-based pharmacological agents: an update | Q34841804 | ||
Selenium levels affect the IL-4-induced expression of alternative activation markers in murine macrophages | Q35173433 | ||
Role of selenium-containing proteins in T-cell and macrophage function | Q35202342 | ||
Selenoprotein synthesis: a unique translational mechanism used by a diverse family of proteins | Q36244481 | ||
Effects of high doses of selenium, as sodium selenite, in septic shock: a placebo-controlled, randomized, double-blind, phase II study | Q36392764 | ||
High affinity selenium uptake in a keratinocyte model | Q36482151 | ||
Selenium geochemistry and health | Q36780022 | ||
Emerging potential of thioredoxin and thioredoxin interacting proteins in various disease conditions | Q37060626 | ||
Methods in determination of selenium states | Q37068551 | ||
Alternatively activated macrophages in infection and autoimmunity | Q37438259 | ||
Selenium and Thyroid Disease: From Pathophysiology to Treatment | Q37640141 | ||
Early Administration of Selenium in Patients with Acute Traumatic Brain Injury: A Randomized Double-blinded Controlled Trial | Q37671338 | ||
Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part I. Biochemical and physiological mechanisms | Q37686284 | ||
Selenium in human health and disease | Q37784804 | ||
Hydrogen sulfide in the mammalian cardiovascular system. | Q37981269 | ||
An original discovery: selenium deficiency and Keshan disease (an endemic heart disease). | Q38019285 | ||
SECIS-binding protein 2 promotes cell survival by protecting against oxidative stress. | Q38349893 | ||
GYY4137, a novel water-soluble, H2S-releasing molecule. | Q38366070 | ||
Effect of high-dose sodium selenite in cardiac surgery patients: A randomized controlled bi-center trial | Q38376825 | ||
Effect of Sodium Selenite Administration and Procalcitonin-Guided Therapy on Mortality in Patients With Severe Sepsis or Septic Shock: A Randomized Clinical Trial | Q38390030 | ||
Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter | Q38409371 | ||
Regulation of Selenium Metabolism and Transport | Q38479916 | ||
Thyroid function in critically ill patients | Q38527069 | ||
A novel slow-releasing hydrogen sulfide donor, FW1256, exerts anti-inflammatory effects in mouse macrophages and in vivo. | Q38809420 | ||
Ebselen, a useful tool for understanding cellular redox biology and a promising drug candidate for use in human diseases | Q38812417 | ||
Selenoprotein P protects endothelial cells from oxidative damage by stimulation of glutathione peroxidase expression and activity | Q40224951 | ||
Involvement of selenoprotein P in protection of human astrocytes from oxidative damage. | Q40288776 | ||
Early selenium treatment for traumatic brain injury: Does it improve survival and functional outcome? | Q40486703 | ||
Dietary selenium modulates activation and differentiation of CD4+ T cells in mice through a mechanism involving cellular free thiols | Q40539049 | ||
Selenium inhibits Staphylococcus aureus-induced inflammation by suppressing the activation of the NF-κB and MAPK signalling pathways in RAW264.7 macrophages | Q40732090 | ||
Selenium-based antihypertensives. Rationale and potential | Q40829775 | ||
Selenium concentrations in the human thyroid gland | Q41138082 | ||
An antithrombotic role for nutritional antioxidants: implications for tumor metastasis and other pathologies | Q41450436 | ||
The effect of parenteral selenium on outcomes of mechanically ventilated patients following sepsis: a prospective randomized clinical trial | Q41479646 | ||
Gaseous Mediators and Mitochondrial Function: The Future of Pharmacologically Induced Suspended Animation? | Q41819432 | ||
The Effect of High-dose Parenteral Sodium Selenite in Critically Ill Patients following Sepsis: A Clinical and Mechanistic Study | Q41921091 | ||
Tissue-specific regulation of selenoenzyme gene expression during selenium deficiency in rats. | Q41991295 | ||
Dynamic pathways of selenium metabolism and excretion in mice under different selenium nutritional statuses. | Q42822287 | ||
The effect of Na-selenite treatment on the oxidative stress-antioxidants balance of multiple organ failure | Q43941160 | ||
On the nature of selenium toxicity and carcinostatic activity | Q43981962 | ||
Effects of acute illness on selenium homeostasis | Q44221391 | ||
Early embryonic lethality caused by targeted disruption of the mouse PHGPx gene | Q44439709 | ||
Selenoprotein P protects low-density lipoprotein against oxidation. | Q44855689 | ||
Restoration of antioxidant enzymes in the therapeutic use of selenium in septic patients | Q44927083 | ||
A review of hydrogen sulfide (H2S) donors: Chemistry and potential therapeutic applications | Q45073955 | ||
Estimation of antioxidant intakes from diet and supplements in U.S. adults | Q46463484 | ||
Randomised trial of glutamine, selenium, or both, to supplement parenteral nutrition for critically ill patients | Q47590936 | ||
Glutathione peroxidase: a selenoenzyme | Q47965043 | ||
The early research and development of ebselen | Q48174053 | ||
Ebselen in acute middle cerebral artery occlusion: a placebo-controlled, double-blind clinical trial | Q48284799 | ||
Selenoproteins and cardiovascular stress | Q50192080 | ||
Effect of selenium supplementation on biochemical markers and outcome in critically ill patients. | Q50711535 | ||
High-dose selenium reduces ventilator-associated pneumonia and illness severity in critically ill patients with systemic inflammation. | Q51044970 | ||
Transport of selenium across the plasma membrane of primary hepatocytes and enterocytes of rainbow trout. | Q51383160 | ||
Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome. | Q53924351 | ||
The discovery of the elements. VI. Tellurium and selenium | Q55878169 | ||
Hypoxia reduces and redirects selenoprotein biosynthesis | Q56966599 | ||
Role of Nitric Oxide in the Cardiovascular and Renal Systems | Q58766337 | ||
Time course and relationship between plasma selenium concentrations, systemic inflammatory response, sepsis, and multiorgan failure | Q61757060 | ||
Circulating Selenium Concentration Is Inversely Associated With the Prevalence of Stroke: Results From the Canadian Health Measures Survey and the National Health and Nutrition Examination Survey. | Q64950520 | ||
The clinical outcomes of selenium supplementation on critically ill patients: A meta-analysis of randomized controlled trials. | Q64970003 | ||
The role of selenium in thyroid hormone metabolism and effects of selenium deficiency on thyroid hormone and iodine metabolism | Q67544647 | ||
Acute pancreatitis--a free radical disease. Decrease in fatality with sodium selenite (Na2SeO3) therapy | Q68244374 | ||
Reduction of the selenotrisulfide derivative of glutathione to a persulfide analog by glutathione reductase | Q68761452 | ||
P433 | issue | 1 | |
P304 | page(s) | 71 | |
P577 | publication date | 2019-12-16 | |
P1433 | published in | Intensive care medicine experimental | Q27726128 |
P1476 | title | Selenium and hydrogen selenide: essential micronutrient and the fourth gasotransmitter? | |
P478 | volume | 7 |
Search more.